Home/Filings/8-K/0001104659-26-002736
8-K//Current report

Senseonics Holdings, Inc. 8-K

Accession 0001104659-26-002736

$SENSCIK 0001616543operating

Filed

Jan 11, 7:00 PM ET

Accepted

Jan 12, 8:25 AM ET

Size

233.9 KB

Accession

0001104659-26-002736

Research Summary

AI-generated summary of this filing

Updated

Senseonics Holdings Reports Preliminary 2025 Revenue and Year-End Cash

What Happened
Senseonics Holdings, Inc. (SENS) filed a Form 8‑K on January 12, 2026 (Items 2.02 and 8.01) and issued a press release with preliminary, unaudited financial and operational updates. The company reported estimated revenue of approximately $14.2 million for Q4 2025 and approximately $35.2 million for the full year ended December 31, 2025, and an estimated cash, cash equivalents and restricted cash balance of about $94.3 million as of year‑end. The filing also noted its patient base grew 103% in Q4 2025 versus Q4 2024. These figures are preliminary and have not been audited.

Key Details

  • Preliminary unaudited revenue: ~$14.2 million for Q4 2025; ~$35.2 million for full year 2025.
  • Preliminary unaudited cash, cash equivalents and restricted cash as of 12/31/2025: ~$94.3 million.
  • Patient base increased 103% in Q4 2025 compared to Q4 2024.
  • Information is preliminary, unaudited and subject to change pending financial close and audit; press release furnished as Exhibit 99.1.

Why It Matters
These preliminary results give investors an early look at Senseonics’ 2025 top-line performance, liquidity position and rapid patient growth—key indicators for revenue sustainability and cash runway. Because the numbers are unaudited and preliminary, investors should wait for the company’s audited 2025 financial statements and formal filings for final figures before making investment decisions.